Literature DB >> 8407063

Serotonergic agonists and antagonists affect endurance performance in the rat.

S P Bailey1, J M Davis, E N Ahlborn.   

Abstract

The purpose of this experiment was to examine the effects of administration of serotonergic (5-HT) agonist and antagonist drugs on run-time to exhaustion (RUN-EXH) in male and female rats. RUN-EXH was reduced (p < 0.05) in a dose related manner by increasing dosages of quipazine dimaleate (QD: general 5-HT agonist) (0-5 mg.kg-1 i.p.) administered immediately prior to exercise (treadmill running at 20 m.min-1 and 5% grade). Conversely, RUN-EXH was increased (p < 0.05) by the greatest dosage of LY 53,857 (LY: 5-HT1C and 5-HT2 antagonist) (1.5 mg.kg-1 i.p.). Drug effects were similar in male and female rats. The negative effects of QD administration on RUN-EXH were not attenuated by administration of the peripherally restricted antagonist, xylamidine tosylate (up to 200 ug.kg-1 i.p.). The results of this investigation indicated that fatigue during prolonged exercise can be influenced by direct pharmacological administration of a serotonergic agonist and antagonist and that the mechanisms underlying these effects are likely to be central (brain) in nature.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407063     DOI: 10.1055/s-2007-1021187

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  25 in total

Review 1.  What are the Physiological Mechanisms for Post-Exercise Cold Water Immersion in the Recovery from Prolonged Endurance and Intermittent Exercise?

Authors:  Mohammed Ihsan; Greig Watson; Chris R Abbiss
Journal:  Sports Med       Date:  2016-08       Impact factor: 11.136

Review 2.  Exercise, learned helplessness, and the stress-resistant brain.

Authors:  Benjamin N Greenwood; Monika Fleshner
Journal:  Neuromolecular Med       Date:  2008-02-26       Impact factor: 3.843

3.  Time trial performance in normal and high ambient temperature: is there a role for 5-HT?

Authors:  Bart Roelands; Maaike Goekint; Luk Buyse; Frank Pauwels; Guy De Schutter; Francesca Piacentini; Hiroshi Hasegawa; Phil Watson; Romain Meeusen
Journal:  Eur J Appl Physiol       Date:  2009-06-17       Impact factor: 3.078

4.  The effect of endurance training on regional serotonin metabolism in the brain during early stage of detraining period in the female rat.

Authors:  Józef Langfort; Elzbieta Barańczuk; Dariusz Pawlak; Małgorzata Chalimoniuk; Nadezda Lukacova; Jozef Marsala; Jan Górski
Journal:  Cell Mol Neurobiol       Date:  2006-08-01       Impact factor: 5.046

5.  Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons.

Authors:  Benjamin N Greenwood; Teresa E Foley; Heidi E W Day; Jay Campisi; Sayamwong H Hammack; Serge Campeau; Steven F Maier; Monika Fleshner
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

6.  The antiserotonin agent pizotifen does not increase endurance performance in humans.

Authors:  J L Pannier; J J Bouckaert; R A Lefebvre
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

7.  Ingestion of branched-chain amino acids and tryptophan during sustained exercise in man: failure to affect performance.

Authors:  G van Hall; J S Raaymakers; W H Saris; A J Wagenmakers
Journal:  J Physiol       Date:  1995-08-01       Impact factor: 5.182

8.  Peripheral serotoninergic response to physical exercise in athletic horses.

Authors:  Daniela Alberghina; Claudia Giannetto; Giuseppe Piccione
Journal:  J Vet Sci       Date:  2010-12       Impact factor: 1.672

9.  Neuroplasticity of dopamine circuits after exercise: implications for central fatigue.

Authors:  Teresa E Foley; Monika Fleshner
Journal:  Neuromolecular Med       Date:  2008-02-15       Impact factor: 3.843

10.  Effect of n-3 fatty acids on free tryptophan and exercise fatigue.

Authors:  Derek M Huffman; Thomas S Altena; Thomas P Mawhinney; Tom R Thomas
Journal:  Eur J Appl Physiol       Date:  2004-03-30       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.